Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios G Papavassiliou

Showing results (51-60 of 523) with videos related to

Pageof 53
Sort By:
Trends in Pharmacological Sciences|December 8, 2006
Multilevel modulation of the mevalonate and protein-prenylation circuitries as a novel strategy for anticancer therapyPanagiotis A Konstantinopoulos, Athanasios G Papavassiliou
Cancers|December 23, 2022
The Biology and Therapeutic Potential of the Src-YAP Axis in Non-Small Cell Lung Cancer (NSCLC)Kostas A Papavassiliou, Athanasios G Papavassiliou
Cells|November 18, 2020
The Multifaceted Output of c-Jun Biological Activity: Focus at the Junction of CD8 T Cell Activation and ExhaustionAthanasios G Papavassiliou, Anna Maria Musti
Pharmacological Research|December 7, 2024
Targeting hypoxia inducible factor-1 alpha in rheumatoid arthritis: Rationale, opportunities and challengesGeorge D Kalliolias, Athanasios G Papavassiliou
Trends in Molecular Medicine|January 15, 2005
Retinoid receptor cross-talk in respiratory epithelium cancer chemopreventionMichalis V Karamouzis, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs|November 26, 2005
17-AAG: mechanisms of antitumour activityPanagiotis A Konstantinopoulos, Athanasios G Papavassiliou
Trends in Molecular Medicine|February 15, 2014
Lysosome: the cell's 'suicidal bag' as a promising cancer targetMelina-Theoni Gyparaki, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs|May 31, 2006
Apoptosis: the suicide solution in cancer treatment and chemopreventionGerasimos P Sykiotis, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs|June 30, 2018
Combination of checkpoint inhibitors with other agents as a strategy to improve anti-cancer effect - a glimpse to the futureMichalis V Karamouzis, Athanasios G Papavassiliou
Critical Reviews in Oncology/Hematology|March 20, 2012
Targeting insulin-like growth factor in breast cancer therapeuticsMichalis V Karamouzis, Athanasios G Papavassiliou
Pageof 53

Showing results (51-60 of 523) with videos related to

Sort By:
Pageof 53
Trends in Pharmacological Sciences|December 8, 2006
Multilevel modulation of the mevalonate and protein-prenylation circuitries as a novel strategy for anticancer therapyPanagiotis A Konstantinopoulos, Athanasios G Papavassiliou
Cancers|December 23, 2022
The Biology and Therapeutic Potential of the Src-YAP Axis in Non-Small Cell Lung Cancer (NSCLC)Kostas A Papavassiliou, Athanasios G Papavassiliou
Cells|November 18, 2020
The Multifaceted Output of c-Jun Biological Activity: Focus at the Junction of CD8 T Cell Activation and ExhaustionAthanasios G Papavassiliou, Anna Maria Musti
Pharmacological Research|December 7, 2024
Targeting hypoxia inducible factor-1 alpha in rheumatoid arthritis: Rationale, opportunities and challengesGeorge D Kalliolias, Athanasios G Papavassiliou
Trends in Molecular Medicine|January 15, 2005
Retinoid receptor cross-talk in respiratory epithelium cancer chemopreventionMichalis V Karamouzis, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs|November 26, 2005
17-AAG: mechanisms of antitumour activityPanagiotis A Konstantinopoulos, Athanasios G Papavassiliou
Trends in Molecular Medicine|February 15, 2014
Lysosome: the cell's 'suicidal bag' as a promising cancer targetMelina-Theoni Gyparaki, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs|May 31, 2006
Apoptosis: the suicide solution in cancer treatment and chemopreventionGerasimos P Sykiotis, Athanasios G Papavassiliou
Expert Opinion on Investigational Drugs|June 30, 2018
Combination of checkpoint inhibitors with other agents as a strategy to improve anti-cancer effect - a glimpse to the futureMichalis V Karamouzis, Athanasios G Papavassiliou
Critical Reviews in Oncology/Hematology|March 20, 2012
Targeting insulin-like growth factor in breast cancer therapeuticsMichalis V Karamouzis, Athanasios G Papavassiliou
Pageof 53